Sun Pharmaceutical receives USFDA approval

Sun Pharmaceutical Industries has informed us that USFDA has granted approval for ANDA to market a generic version of medimmune’s ethyol, amifostine for injection 500mg.

This generic amifostine for injection is therapeutically equivalent to medimmune’s ethyol amifostine for injection 500mg. Ethyol has annual sales of approximately US$ 80 million in the US.

Sun Pharma, being the first-to-file an ANDA for generic ethyol with a para IV certification, has a 180-day marketing exclusivity.

Amifostine is used as an adjuvant in cancer treatment. Sun Pharma’s amifostine for Injection will be indicated for the reduction of kidney damage in patients who have advanced ovarian cancer and are being given repeat doses of cisplatin.

Merrill Lynch sells Reliance Energy + Jai Corp

Caught in the sub-prime web, FIIs are unwinding their positions in Shangri-La companies like Reliance Energy, Jai Corp etc. Here is what they have sold.

Merrill Lynch Cap-Espana
Reliance Energy 3.40 mn shares
Jai Corp 2.65 mn shares

Citigroup Global-Mauritius sold
Ruchi Soya 2.50 mn shares
Jet Airways 0.50 mn shares

Goldman Sachs sold
Indian Overseas Bk 18.96 mn shares
Punjab National Bk 15.26 mn shares

BSMA has sold
Sonata Software 2.10 mn shares
Dabur Pharma 1.31 mn shares

Details here.

Sub-Prime Hall of Shame

Here is the Sub-prime hall of shame. Bank followed by write-offs till date.

  • Merrill Lynch $24.4 bln
  • UBS $18.4 bln
  • Citigroup $18.1 bln
  • Carlyle Capital $16.6 bln – Debt Defaults
  • Morgan Stanley $9.4 bln
  • Bank of America $5.3 bln
  • Capital One $4.9-5.5 bln Credit losses
  • Soc Gen $4.2bn Sub Prime Asset Mgmt
  • RBS $4.2 bn – Investment Banking
  • Citigroup Consumer Loans $4.1 bn
  • Barclays $3.1 bn
  • Credit Suisse $2.85 bn – Asset backed investment
  • HSBC $2.1 bn – Mortgages
  • Bear Stearns $1.9 bn
  • Wachovia $1.5 bn – Credit losses
  • JP Morgan $1.3 bn

More expected at the end of March quarter, 2008.

Life Insurers Market Share

We had an exclusive market research on the market share of private life insurance companies in India. Data indicated in the research is as of Feb-2008. The top 5 private life insurance companies in India are,

  • ICICI Prudential Life Insurance
  • Bajaj Allianz
  • SBI Life [Part of the SBI group, though no direct interference of Govt of India]
  • HDFC Standard Life
  • Reliance Life

Market share of other insurance companies is as shown above in the pie-chart.

Enam on Motherson Sumi Systems

ENAM Securities continues to rate Motherson Sumi Systems [MSSL] as an OUTPERFORMER but with realistic returns expectations. MSSL has dominated the domestic wiring harness market with a ~65% market share. Long standing relationships with most OEMs and backward integration for critical components will ensure MSSL’s dominance. Increasing complexity of cars to leading to greater value addition, and higher realizations for MSSL.

Sumitomo wiring systems (SWS) has identified India as a “focused frontier” where they expect growth. India/ Sharjah likely to emerge as a significant sourcing base for Sumitomo over the next 3-4 years. (more…)

Performance Analysis of IPOs in 2007

You are reading this first here on the World Wide WebIPOs in India dried up all of a sudden. Adding to the woes of promoters is poor Industrial Production numbers which led to a massive sell-off on the exchanges. Our IPO Analyst decided to track the performance of folks who have raised money in 2007. Out of the approximately 95 companies that raised money from Retail Investors in India by IPO, 60% are quoting below their issue price.

Remember, these are the same issues where retailers flocked by looking at FII subscription. However, FIIs have also turned speculators in the primary market and have sold aggressively.

Below is the list which our analyst has provided.

Sl. No, Company Name, Last Traded Price, Issue Price, Premium/Discount
1 Broadcast Initiatives Limited 30.5 120 -75%
2 House of Pearl Fashions Limited 164.5 550 -70%
3 IVR Prime Urban Developers Limited 196.8 550 -64% (more…)